Literature DB >> 17826046

Use of cyclodextrins in topical formulations: practical aspects.

Krzysztof Cal1, Katarzyna Centkowska.   

Abstract

Cyclodextrins are promising, but using them as an excipients can sometimes be difficult. The aim of this review is to summarize the results of recent studies on the application of parent cyclodextrins (alpha-, beta-, gamma-) and some of their derivatives in topical formulations. General properties, current legal status, and toxicological aspects of cyclodextrins are briefly described. The goal of using cyclodextrins to create new formulations with well-known actives, advantages, and limitations in topical formulations is presented, and possible applications in such preparations are also discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826046     DOI: 10.1016/j.ejpb.2007.08.002

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  12 in total

1.  Host-guest interactions mediated nano-assemblies using cyclodextrin-containing hydrophilic polymers and their biomedical applications.

Authors:  Jianxiang Zhang; Peter X Ma
Journal:  Nano Today       Date:  2010-08-01       Impact factor: 20.722

2.  Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent.

Authors:  Navjot Kaur; Richa Puri; Subheet Kumar Jain
Journal:  AAPS PharmSciTech       Date:  2010-03-24       Impact factor: 3.246

3.  Antifungal activity improved by coproduction of cyclodextrins and anabaenolysins in Cyanobacteria.

Authors:  Tania K Shishido; Jouni Jokela; Clara-Theresia Kolehmainen; David P Fewer; Matti Wahlsten; Hao Wang; Leo Rouhiainen; Ermanno Rizzi; Gianluca De Bellis; Perttu Permi; Kaarina Sivonen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-16       Impact factor: 11.205

4.  Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-β-cyclodextrin complex for ophthalmic delivery.

Authors:  Haohao Zhang; Meiwan Chen; Zixin He; Zhouhua Wang; Meimei Zhang; Zhouyang He; Qian Wan; Dan Liang; Michael A Repka; Chuanbin Wu
Journal:  AAPS PharmSciTech       Date:  2012-11-17       Impact factor: 3.246

5.  The effect of doxycycline temperature-sensitive hydrogel on inhibiting the corneal neovascularization induced by BFGF in rats.

Authors:  Wenru Su; Zhanrong Li; Miaoli Lin; Yongping Li; Zixin He; Chuanbin Wu; Dan Liang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-16       Impact factor: 3.117

6.  Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells.

Authors:  Lingling Xu; Chuan Zhou; Fan Wang; Huiqin Liu; Guangyuan Dong; Siyi Zhang; Tao Liu
Journal:  RSC Adv       Date:  2022-06-17       Impact factor: 4.036

7.  Synthesis of the Anionic Hydroxypropyl-β-cyclodextrin:Poly(decamethylenephosphate) Polyrotaxane and Evaluation of its Cholesterol Efflux Potential in Niemann-Pick C1 Cells.

Authors:  Kerstin Egele; Shayak Samaddar; Nina Schneider; David Thompson; Gerhard Wenz
Journal:  J Mater Chem B       Date:  2018-12-07       Impact factor: 6.331

8.  Preparation and evaluation of lidocaine hydrochloride in cyclodextrin inclusion complexes for development of stable gel in association with chlorhexidine gluconate for urogenital use.

Authors:  Luiz Francisco Jones Soares da Silva; Flavia Almada do Carmo; Vinicius Raphael de Almeida Borges; Lidiane Mota Monteiro; Carlos Rangel Rodrigues; Lúcio Mendes Cabral; Valeria Pereira de Sousa
Journal:  Int J Nanomedicine       Date:  2011-06-03

9.  A Dispersion Corrected DFT Investigation of the Inclusion Complexation of Dexamethasone with β-Cyclodextrin and Molecular Docking Study of Its Potential Activity against COVID-19.

Authors:  Youghourta Belhocine; Seyfeddine Rahali; Hamza Allal; Ibtissem Meriem Assaba; Monira Galal Ghoniem; Fatima Adam Mohamed Ali
Journal:  Molecules       Date:  2021-12-15       Impact factor: 4.411

Review 10.  Photosensitive drugs: a review on their photoprotection by liposomes and cyclodextrins.

Authors:  Giuseppina Ioele; Michele De Luca; Antonio Garofalo; Gaetano Ragno
Journal:  Drug Deliv       Date:  2017-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.